Today: 18 January 2026
Subscribe
Browse Category

Risk Management News 9 December 2025 - 20 December 2025

BHP Group Ltd Stock (BHP): Latest News, Key Risks, and 2026 Forecasts as of Dec. 20, 2025

BHP Group Ltd Stock (BHP): Latest News, Key Risks, and 2026 Forecasts as of Dec. 20, 2025

BHP Group Ltd stock is ending 2025 with a familiar, slightly paradoxical vibe: the long-term “electrification” narrative is alive and well thanks to copper, but the near-term “China + iron ore” reality still has the steering wheel. As of the latest trade timestamp on Saturday, Dec. 20, 2025, BHP’s US-listed ADR last traded around $59.32. Below is a roundup of…
20 December 2025
····
TeraWulf (WULF) Stock Slides on Dec. 15, 2025: Preferred Conversion, Google-Backed AI Data Center Pivot, Analyst Forecasts, and Key Risks to Watch

TeraWulf (WULF) Stock Slides on Dec. 15, 2025: Preferred Conversion, Google-Backed AI Data Center Pivot, Analyst Forecasts, and Key Risks to Watch

December 15, 2025 (15.12.2025) — Shares of TeraWulf Inc. (NASDAQ: WULF) traded sharply lower Monday as investors weighed a familiar crypto-miner headwind (a softer Bitcoin tape) against a much newer narrative: TeraWulf’s rapid evolution into a high-performance computing (HPC) / AI data center infrastructure platform with long-duration, credit-enhanced leases. As of early afternoon trading, WULF was around $12.9, down roughly…
15 December 2025
····
Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Inc. (NYSE: KVUE)—the consumer health company behind brands such as Tylenol, Band-Aid, Listerine, Neutrogena, and Aveeno—is trading in a market that feels less like “buy-and-hold fundamentals” and more like “event-driven probability.” The reason: Kimberly-Clark’s planned acquisition of Kenvue, a deal that has put a very visible “price anchor” on KVUE… while lawsuits, regulatory steps, and the calendar to closing…
15 December 2025
····
Reckitt Benckiser (RKT.L) Stock News, Forecasts and Analysis on 13 December 2025: Buybacks, Emerging-Market Momentum, and Key Risks Ahead

Reckitt Benckiser (RKT.L) Stock News, Forecasts and Analysis on 13 December 2025: Buybacks, Emerging-Market Momentum, and Key Risks Ahead

London, 13 December 2025 — Reckitt Benckiser Group plc (LSE: RKT) heads into mid‑December with its shares hovering around the psychologically important 6,000p level after a strong year, as investors weigh three big forces: a steady stream of share buybacks, faster growth in emerging markets (especially China and India), and the ongoing legal overhang tied to U.S. infant-formula (NEC) litigation.…
13 December 2025
····
Strategy (MSTR) Stock After Hours (Dec. 12, 2025): Nasdaq-100 Risk, MSCI Index Threat, and What to Watch Before the Next Market Open

Strategy (MSTR) Stock After Hours (Dec. 12, 2025): Nasdaq-100 Risk, MSCI Index Threat, and What to Watch Before the Next Market Open

NEW YORK — December 12, 2025 — Strategy Inc. (NASDAQ: MSTR)—the company formerly known as MicroStrategy—ended Friday’s session under pressure and traded slightly lower after the closing bell, as investors weighed a fresh wave of index-related uncertainty and the company’s continued identity shift into a Bitcoin-heavy “digital asset treasury” model. Reuters Below is what happened after the bell on 12/12/2025,…
12 December 2025
····
Nike Stock (NKE) News & Forecast for Dec. 12, 2025: Analyst Calls, Earnings Preview, and Key Risks

Nike Stock (NKE) News & Forecast for Dec. 12, 2025: Analyst Calls, Earnings Preview, and Key Risks

(SEO): Nike stock (NYSE: NKE) trades higher into the Dec. 18 earnings report as analysts debate a turnaround under CEO Elliott Hill amid tariff pressure, inventory cleanup, and fresh regulatory scrutiny. Updated: December 12, 2025 Nike, Inc. (NYSE: NKE) is heading into a pivotal week for shareholders. On Friday, Dec. 12, 2025, Nike shares were among notable Dow movers, rising…
12 December 2025
····
UltraGreen.ai Limited Stock (SGX: ULG) Today: Latest Price, IPO Stabilisation Updates, Analyst Forecasts and Key Risks — December 12, 2025

UltraGreen.ai Limited Stock (SGX: ULG) Today: Latest Price, IPO Stabilisation Updates, Analyst Forecasts and Key Risks — December 12, 2025

UltraGreen.ai Limited (SGX: ULG) is still in that fascinating (and often chaotic) early post-IPO phase: heavy attention, fast-moving headlines, and price discovery happening in public. As of December 12, 2025, UltraGreen.ai shares were trading at US$1.430, down 1.38% on the day, with a US$1.420–US$1.450 intraday range and about 2.39 million shares traded (timestamped at 15:18 on the quote source). SG…
12 December 2025
····
DoorDash (DASH) Stock Forecast After the Q3 2025 Selloff: Price Targets, 2026 Outlook and Key Risks

DoorDash (DASH) Stock Forecast After the Q3 2025 Selloff: Price Targets, 2026 Outlook and Key Risks

DoorDash, Inc. (NYSE: DASH) has had a wild 2025. After a sharp post‑earnings selloff in early November, the stock slumped into late November — then began clawing its way back. As of midday on December 11, 2025, DoorDash trades around $220–221 per share, down from its 52‑week high near $285 but well above the late‑November lows. StockAnalysis Despite the volatility,…
11 December 2025
···
Plug Power Stock (PLUG) in December 2025: NASA Contract, Fresh Cash and a High‑Risk Outlook for Investors

Plug Power Stock (PLUG) in December 2025: NASA Contract, Fresh Cash and a High‑Risk Outlook for Investors

Where Plug Power Stock Stands on December 10, 2025 Plug Power Inc. (NASDAQ: PLUG), the hydrogen fuel‑cell and electrolyzer company, remains one of the most volatile names in clean energy. As of the latest trade on December 10, 2025, PLUG is changing hands at about $2.19 per share, with an intraday range between roughly $2.16 and $2.24 and volume north…
10 December 2025
····
Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Published: December 10, 2025 – Ticker: NASDAQ: CPB Snapshot: What’s Happening to Campbell’s Stock Today? The Campbell’s Company (formerly Campbell Soup Company) is under real pressure in the market. Shares fell more than 5% on December 9 after earnings and continued lower today; some data providers note the stock is headed for its lowest levels since the late 2000s. Tikr…
10 December 2025
····
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics Inc. (NASDAQ: SMMT) continues to trade like a classic high-beta biotech: big promises in lung cancer, plenty of red flags, and a stock price stuck near the lower end of its 52-week range while analysts project eye-popping upside. As of the latest US session on December 9, 2025, SMMT is trading around $17–18 per share, versus a 52-week…
9 December 2025
····
Playboy, Inc. (PLBY) Stock in 2025: First Profit, Licensing Pivot and High‑Risk Upside – What Investors Need to Know Now

Playboy, Inc. (PLBY) Stock in 2025: First Profit, Licensing Pivot and High‑Risk Upside – What Investors Need to Know Now

Date: December 9, 2025 Playboy, Inc. (NASDAQ: PLBY) has quietly turned into one of the more polarizing small‑cap stories on the market. The iconic brand has posted its first quarterly profit since going public, pushed through a radical shift to an “asset‑light” licensing model, won an $81 million arbitration award, and staged a sharp year‑to‑date rally in its share price.…
9 December 2025
····
1 2 3 4 5 6

Stock Market Today

  • Butterfly Network Valuation After NYSE Warrant Delisting and Revenue Guidance
    January 17, 2026, 11:03 PM EST. Butterfly Network (BFLY) is back in focus after the NYSE moved to delist its publicly traded warrants. Its Class A common stock continues trading, and fresh revenue guidance has drawn fresh attention. At US$4.16, the stock posted a 90-day return of 76.27% and a 30-day gain of 16.85%; 1-year TSR stood at 13.35% and 3-year TSR at 55.81%, signaling renewed momentum after the warrant delisting news and guidance. A rough fair value assessment near US$4.19 suggests current prices are in line with near-term growth expectations. Risks include stalled enterprise deals, weaker software renewals, and ongoing heavy R&D spend that could pressure margins. The stock trades at a P/S ratio about 11.9x, well above the medical equipment peer group, prompting questions about the growth premium.
Go toTop